voxelotor
Global Blood Therapeutics
[]
$gbt gbt presents positive new real-world evidence data at eha2022 congress further supporting clinical use of oxbryta (voxelotor) in sickle cell disease 
GetOnTrade is a news platform to help you stay up-to-date with the latest stock market news. We are not financial advisor(please do your own due diligence).